Artwork
iconShare
 
Manage episode 372403756 series 3423840
Content provided by Skytale Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Skytale Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

On this week’s episode of Skytale Insights, we welcome JD Schaub, EVP and Chief Operating Officer at RVL Pharmaceuticals, to the podcast! JD and Judy Kozlicki sat down to discuss Upneeq, an innovative FDA approved prescription eyedrop for acquired ptosis!

Judy and JD talk about advances in ocular aesthetics and the making of Upneeq. Plus, JD gives us a behind the scenes look at RVL Pharma and the studies performed to create this new innovative prescription eyedrop.
Connect with JD Schaub:

Connect with Skytale Group:

  continue reading

62 episodes